申请人:Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
公开号:EP3656769A1
公开(公告)日:2020-05-27
Disclosed is a class of new aryl-phosphorus-oxygen compounds as shown in formula (I) as EGFR kinase inhibitors, and pharmaceutically acceptable salts thereof.
公开了一类如式(I)所示的作为
表皮生长因子受体激酶
抑制剂的新型芳基
磷氧化合物及其药学上可接受的盐类。